Novel host restriction factors implicated in HIV-1 replication

The Journal of General Virology
Dibya GhimireRitu Gaur

Abstract

Human immunodeficiency virus-1 (HIV-1) is known to interact with multiple host cellular proteins during its replication in the target cell. While many of these host cellular proteins facilitate viral replication, a number of them are reported to inhibit HIV-1 replication at various stages of its life cycle. These host cellular proteins, which are known as restriction factors, constitute an integral part of the host's first line of defence against the viral pathogen. Since the discovery of apolipoprotein B mRNA-editing enzyme 3G (APOBEC3G) as an HIV-1 restriction factor, several human proteins have been identified that exhibit anti-HIV-1 restriction. While each restriction factor employs a distinct mechanism of inhibition, the HIV-1 virus has equally evolved complex counter strategies to neutralize their inhibitory effect. APOBEC3G, tetherin, sterile alpha motif and histidine-aspartate domain 1 (SAMHD1), and trim-5α are some of the best known HIV-1 restriction factors that have been studied in great detail. Recently, six novel restriction factors were discovered that exhibit significant antiviral activity: endoplasmic reticulum α1,2-mannosidase I (ERManI), translocator protein (TSPO), guanylate-binding protein 5 (GBP5), serine i...Continue Reading

References

Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·C Braestrup, R F Squires
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M W McEneryS H Snyder
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R PalM G Sarngadharan
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B D WalkerJ Sodroski
May 1, 1986·Nature·J CoffinP Vogt
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D C MontefioriW M Mitchell
Jan 1, 1985·Annual Review of Biochemistry·R Kornfeld, S Kornfeld
Nov 5, 1997·Current Opinion in Structural Biology·B Henrissat, G Davies
Sep 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·H M CraigJ C Guatelli
Dec 3, 1999·Science·L EllgaardA Helenius
Sep 21, 2000·The Journal of Biological Chemistry·F ValleeP L Howell
Dec 9, 2000·The Journal of Biological Chemistry·R BrouwerG J Pruijn
Jun 20, 2001·Nature Reviews. Molecular Cell Biology·N Zamzami, G Kroemer
Feb 26, 2003·Cell·Donald D Newmeyer, Shelagh Ferguson-Miller
Jun 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ying WuRichard N Sifers
Oct 15, 2003·Journal of Virology·Matthew J BickMargaret R MacDonald
Jun 11, 2004·Annual Review of Biochemistry·Ari Helenius, Markus Aebi
Jul 23, 2004·PLoS Biology·Sara L SawyerHarmit S Malik
Feb 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sara L SawyerHarmit S Malik
Aug 27, 2005·The Journal of Biological Chemistry·Madoka InuzukaTatsuya Ingi
Dec 15, 2005·The Journal of Biological Chemistry·Weiguo Zou, Dong-Er Zhang
May 13, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Maureen A OlszewskiDeborah J Vestal
Aug 30, 2006·Current Opinion in Structural Biology·Kelley W Moremen, Maurizio Molinari
Nov 23, 2006·Methods in Enzymology·Steven W Mast, Kelley W Moremen
Dec 22, 2006·Journal of Virology·Stefanie MüllerBeate M Kümmerer
Jun 22, 2007·Proceedings of the National Academy of Sciences of the United States of America·Yi YangJoseph Loscalzo
Jun 26, 2008·Retrovirology·Ritu Goila-Gaur, Klaus Strebel
Nov 29, 2008·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Michael H Malim

❮ Previous
Next ❯

Citations

Jan 24, 2020·JAMA : the Journal of the American Medical Association·Catharine I PaulesAnthony S Fauci
Feb 6, 2020·The International Journal of Occupational and Environmental Medicine·Parham Habibzadeh, Emily K Stoneman
Feb 14, 2020·The Journal of Antimicrobial Chemotherapy·Marie-Angélique De ScheerderLinos Vandekerckhove
Jul 14, 2020·Immunological Reviews·Inna G OvsyannikovaRichard B Kennedy
Jul 30, 2020·PLoS Pathogens·Margarida Sa RiberoSébastien Nisole
Sep 25, 2018·Nucleic Acids Research·Zhaolong LiWenyan Zhang
May 6, 2020·Viruses·Rayhane NchiouaFrank Kirchhoff
May 22, 2019·Viruses·Scott P Kenney
May 16, 2020·Frontiers in Bioengineering and Biotechnology·Mai IzumidaYoshinao Kubo
Jun 30, 2019·Current Opinion in Virology·Cecilio Lopez-GalindezRamon Lorenzo-Redondo
Jan 16, 2021·ELife·Daniel Sauter, Frank Kirchhoff
Jun 8, 2021·Molecular Biology Reports·Elsie Guadalupe Hernández-LópezAna Rosa Rincón-Sánchez
Jul 27, 2021·Frontiers in Cell and Developmental Biology·Lucas A TavaresLuis L P daSilva
Jun 6, 2020·ACS Infectious Diseases·Emmanuel E NekongoMatthew D Shoulders

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Current Infectious Disease Reports
Sarah Sebastian, Jeremy Luban
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Yan-Chang LeiDong-Liang Yang
Cold Spring Harbor Perspectives in Medicine
M H Malim, Paul D Bieniasz
© 2022 Meta ULC. All rights reserved